Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3343586
Max Phase: Preclinical
Molecular Formula: C30H38N5O11PS2
Molecular Weight: 739.77
Molecule Type: Small molecule
Associated Items:
ID: ALA3343586
Max Phase: Preclinical
Molecular Formula: C30H38N5O11PS2
Molecular Weight: 739.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(OC(C)C(C)S(=O)(=O)c3ccccc3)OC(C)C(C)S(=O)(=O)c3ccccc3)O2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C30H38N5O11PS2/c1-19-17-35(30(37)32-29(19)36)28-16-26(33-34-31)27(44-28)18-43-47(38,45-20(2)22(4)48(39,40)24-12-8-6-9-13-24)46-21(3)23(5)49(41,42)25-14-10-7-11-15-25/h6-15,17,20-23,26-28H,16,18H2,1-5H3,(H,32,36,37)/t20?,21?,22?,23?,26-,27+,28+,47?/m0/s1
Standard InChI Key: FWKFZBOTDMHNLP-ISMLXNILSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 739.77 | Molecular Weight (Monoisotopic): 739.1747 | AlogP: 4.47 | #Rotatable Bonds: 15 |
Polar Surface Area: 225.89 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.96 | CX Basic pKa: | CX LogP: 3.89 | CX LogD: 3.78 |
Aromatic Rings: 3 | Heavy Atoms: 49 | QED Weighted: 0.10 | Np Likeness Score: 0.13 |
1. Wang J, Wang YJ, Chen ZS, Kwon CH.. (2014) Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs., 22 (21): [PMID:25440502] [10.1016/j.bmc.2014.09.046] |
Source(1):